Jan 17, 2023 08:40AM
Jan 17, 2023 08:00AM
Nov 14, 2022 04:05PM
Sep 28, 2022 04:09PM
Sep 28, 2022 04:09PM
Aug 9, 2022 04:15PM
May 17, 2022 08:08AM Idera Pharma (IDRA) Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC, Enrollment Stopped Early for Efficacy
May 17, 2022 08:04AM
May 5, 2022 04:15PM
Mar 31, 2022 04:15PM
Dec 14, 2021 04:32PM
Dec 14, 2021 04:32PM
Nov 8, 2021 04:14PM
Aug 9, 2021 04:15PM Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Apr 29, 2021 04:10PM
Apr 5, 2021 04:21PM
Apr 5, 2021 04:20PM
Mar 18, 2021 04:16PM
Mar 18, 2021 04:15PM
Mar 1, 2021 04:35PM
Jan 11, 2021 06:02AM Idera Pharmaceuticals to Present at Upcoming Conferences
Dec 15, 2020 08:13AM
Dec 15, 2020 08:05AM
Nov 17, 2020 04:27PM
Nov 17, 2020 04:27PM
Oct 29, 2020 04:36PM
Sep 28, 2020 08:45AM
Sep 28, 2020 08:45AM Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
Sep 15, 2020 07:18AM
Aug 4, 2020 04:10PM
Jul 15, 2020 08:05AM
Jul 15, 2020 08:05AM
Jun 2, 2020 08:16AM
Jun 2, 2020 08:15AM
May 1, 2020 08:00AM Idera Pharmaceuticals Announces Change of Location for 2020 Annual Meeting of Stockholders
Apr 30, 2020 04:35PM
Apr 23, 2020 07:30AM
Apr 21, 2020 07:34AM
Apr 21, 2020 07:30AM
Apr 7, 2020 04:11PM
Apr 7, 2020 04:05PM
Mar 12, 2020 07:30AM Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Mar 5, 2020 07:00AM
Jan 14, 2020 07:01AM
Jan 14, 2020 07:00AM
Dec 23, 2019 09:22AM
Dec 23, 2019 09:15AM
Nov 6, 2019 04:01PM
Oct 21, 2019 07:04AM Idera Pharma (IDRA) Announces New U.S. Patent For Tilsotolimod Through September 2037
Oct 21, 2019 07:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All